Literature DB >> 20855625

Polymorphic genetic control of tumor invasion in a mouse model of pancreatic neuroendocrine carcinogenesis.

Matthew G H Chun1, Jian-Hua Mao, Christopher W Chiu, Allan Balmain, Douglas Hanahan.   

Abstract

Cancer is a disease subject to both genetic and environmental influences. In this study, we used the RIP1-Tag2 (RT2) mouse model of islet cell carcinogenesis to identify a genetic locus that influences tumor progression to an invasive growth state. RT2 mice inbred into the C57BL/6 (B6) background develop both noninvasive pancreatic neuroendocrine tumors (PNET) and invasive carcinomas with varying degrees of aggressiveness. In contrast, RT2 mice inbred into the C3HeB/Fe (C3H) background are comparatively resistant to the development of invasive tumors, as are RT2 C3HB6(F1) hybrid mice. Using linkage analysis, we identified a 13-Mb locus on mouse chromosome 17 with significant linkage to the development of highly invasive PNETs. A gene residing in this locus, the anaplastic lymphoma kinase (Alk), was expressed at significantly lower levels in PNETs from invasion-resistant C3H mice compared with invasion-susceptible B6 mice, and pharmacological inhibition of Alk led to reduced tumor invasiveness in RT2 B6 mice. Collectively, our results demonstrate that tumor invasion is subject to polymorphic genetic control and identify Alk as a genetic modifier of invasive tumor growth.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20855625      PMCID: PMC2951397          DOI: 10.1073/pnas.1012705107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  The latent transforming growth factor beta binding protein (LTBP) family.

Authors:  R Oklü; R Hesketh
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

2.  Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.

Authors:  D Hanahan
Journal:  Nature       Date:  1985 May 9-15       Impact factor: 49.962

Review 3.  The genetics and genomics of cancer.

Authors:  Allan Balmain; Joe Gray; Bruce Ponder
Journal:  Nat Genet       Date:  2003-03       Impact factor: 38.330

4.  Oncogene expression and genetic background influence the frequency of DNA copy number abnormalities in mouse pancreatic islet cell carcinomas.

Authors:  Jeffrey H Hager; J Graeme Hodgson; Jane Fridlyand; Sujatmi Hariono; Joe W Gray; Douglas Hanahan
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

5.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

6.  Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis.

Authors:  Theresa Lopez; Douglas Hanahan
Journal:  Cancer Cell       Date:  2002-05       Impact factor: 31.743

7.  Distinct genetic loci control development of benign and malignant skin tumours in mice.

Authors:  H Nagase; S Bryson; H Cordell; C J Kemp; F Fee; A Balmain
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

Review 8.  Cancer susceptibility in the mouse: genetics, biology and implications for human cancer.

Authors:  Peter Demant
Journal:  Nat Rev Genet       Date:  2003-09       Impact factor: 53.242

9.  FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.

Authors:  H Hennings; A B Glick; D T Lowry; L S Krsmanovic; L M Sly; S H Yuspa
Journal:  Carcinogenesis       Date:  1993-11       Impact factor: 4.944

10.  Genetic deletion of the desmosomal component desmoplakin promotes tumor microinvasion in a mouse model of pancreatic neuroendocrine carcinogenesis.

Authors:  Matthew G H Chun; Douglas Hanahan
Journal:  PLoS Genet       Date:  2010-09-16       Impact factor: 5.917

View more
  10 in total

Review 1.  The dark side of synaptic proteins in tumours.

Authors:  Jing Li; Yalan Xu; Hai Zhu; Yin Wang; Peifeng Li; Dong Wang
Journal:  Br J Cancer       Date:  2022-05-27       Impact factor: 9.075

2.  Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors.

Authors:  Barbara Sennino; Toshina Ishiguro-Oonuma; Ying Wei; Ryan M Naylor; Casey W Williamson; Vikash Bhagwandin; Sebastien P Tabruyn; Weon-Kyoo You; Harold A Chapman; James G Christensen; Dana T Aftab; Donald M McDonald
Journal:  Cancer Discov       Date:  2012-02-24       Impact factor: 39.397

3.  Cancer Cells Retrace a Stepwise Differentiation Program during Malignant Progression.

Authors:  Sadegh Saghafinia; Iacovos P Michael; Krisztian Homicsko; Annunziata Di Domenico; Stephan Wullschleger; Aurel Perren; Ilaria Marinoni; Giovanni Ciriello; Douglas Hanahan
Journal:  Cancer Discov       Date:  2021-04-28       Impact factor: 39.397

4.  ¹H NMR based serum metabolic profiles associated with pathological progression of pancreatic islet β cell tumor in Rip1-Tag2 mice.

Authors:  Yongxia Yang; Ying Liu; Lingyun Zheng; Qianqian Zhang; Quliang Gu; Linlin Wang; Lijing Wang
Journal:  Int J Biol Sci       Date:  2015-04-05       Impact factor: 6.580

5.  Sexual dimorphism of liver metastasis by murine pancreatic neuroendocrine tumors is affected by expression of complement C5.

Authors:  Tanupriya Contractor; Shinta Kobayashi; Edaise da Silva; Richard Clausen; Chang Chan; Evan Vosburgh; Laura H Tang; Arnold J Levine; Chris R Harris
Journal:  Oncotarget       Date:  2016-05-24

6.  A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis.

Authors:  Iacovos P Michael; Sadegh Saghafinia; Douglas Hanahan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-08       Impact factor: 11.205

7.  ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers.

Authors:  Anton Wellstein
Journal:  Front Oncol       Date:  2012-12-19       Impact factor: 6.244

8.  Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.

Authors:  Elizabeth Allen; Pascal Miéville; Carmen M Warren; Sadegh Saghafinia; Leanne Li; Mei-Wen Peng; Douglas Hanahan
Journal:  Cell Rep       Date:  2016-04-28       Impact factor: 9.423

9.  GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth.

Authors:  Leanne Li; Qiqun Zeng; Arjun Bhutkar; José A Galván; Eva Karamitopoulou; Daan Noordermeer; Mei-Wen Peng; Alessandra Piersigilli; Aurel Perren; Inti Zlobec; Hugh Robinson; M Luisa Iruela-Arispe; Douglas Hanahan
Journal:  Cancer Cell       Date:  2018-03-29       Impact factor: 31.743

10.  Distinct Response of Circulating microRNAs to the Treatment of Pancreatic Cancer Xenografts with FGFR and ALK Kinase Inhibitors.

Authors:  Ivana Peran; Eveline E Vietsch; Gai Yan; Anna T Riegel; Anton Wellstein
Journal:  Cancers (Basel)       Date:  2022-03-16       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.